Anti-Chlamydia Trachomatis LPS [Clone CL21-335.2.3] - 100 μg

Chlamydia trachomatis is a significant global health concern and the most frequently reported sexually transmitted bacterial infection (STD) in the United States, responsible for over one million annual cases. This gram-negative bacterium infects the columnar epithelium of the cervix, urethra, and rectum, as well as non-genital sites like the lungs and eyes. The study and detection of key bacterial components, such as Lipopolysaccharide (LPS), is crucial for diagnostics and research, especially since the infection is often asymptomatic. Untreated C. trachomatis infection can lead to serious complications, including pelvic inflammatory disease (PID), infertility, and ectopic pregnancy in women, and epididymitis and orchitis in men. Researchers and diagnostic developers rely on highly specific tools like an Anti-Chlamydia trachomatis LPS Monoclonal Antibody for accurate analysis and screening.